Top Section/Ad
Top Section/Ad
Most recent
International tension has propelled valuations in the sector up, tempting issuers
Czech defence firm priced at a discount to German competitor Rheinmetall
Czech defence firm set for largest European IPO since Porsche's 2022 listing
Listing meant to give government fiscal breathing room
More articles/Ad
More articles/Ad
More articles
-
Chaoju Eye Care Holdings is gauging investor appetite for a HK$1.81bn ($233m) listing on the Hong Kong Stock Exchange, becoming the latest healthcare related company to seek an IPO. -
Chinese technology companies are flocking back to the US for IPOs after months of poor market conditions and the regulatory crackdown on the sector brought deal flow to a near halt. There is more on the way too, as issuers look to wrap up deals before the summer slowdown. Jonathan Breen reports.
-
Biopharmaceutical company HutchMed (China) pocketed HK$4.17bn ($537.1m) this week from its Hong Kong IPO.
-
This week, Spanish refrigerated trucking company Primafrio and Russian goldminer Nordgold postponed their respective IPOs, on the Spanish and London Stock Exchanges in hopes of better market conditions in the future. These delays are just the latest casualties of Europe’s turbulent IPO market.
-
Dingdong (Cayman), a Chinese e-commerce company for fresh groceries, and its rival Missfresh are testing investor appetite at the same time for their US IPOs.
-
The European initial public offering market has been difficult for months, but new listings are still being brought to market with little regard for whether investors want to buy them. Instead of trying to ram deals through to satisfy a pre-arranged timeline, banks should be advising their clients to delay listings that don’t work in these conditions.
